Protagonist Therapeutics, Inc (PTGX) /
The revenue of Protagonist Therapeutics, Inc over the past 10 years
Chart Protagonist Therapeutics, Inc: revenue, fiscal 2016–2025 Open the chart →Protagonist Therapeutics, Inc reported revenue of $46.02M in fiscal 2025, the latest fiscal year on file. In fiscal 2017 it was $20.06M — up 129% over 8 years. Year over year, revenue rose 4 times and fell 4 times. In these years the highest was $434.43M in fiscal 2024; the lowest $231K in fiscal 2019. The largest one-year move was in fiscal 2020: up 12293%, from $231K to $28.63M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $46.02M |
| 2024ended Dec 31, 2024 | $434.43M |
| 2023ended Dec 31, 2023 | $60M |
| 2022ended Dec 31, 2022 | $26.58M |
| 2021ended Dec 31, 2021 | $27.36M |
| 2020ended Dec 31, 2020 | $28.63M |
| 2019ended Dec 31, 2019 | $231K |
| 2018ended Dec 31, 2018 | $30.93M |
| 2017ended Dec 31, 2017 | $20.06M |
| 2016ended Dec 31, 2016 | — |
Fiscal years as Protagonist Therapeutics, Inc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Protagonist Therapeutics, Inc
- The profitability of Protagonist Therapeutics, Inc
- The cash flow of Protagonist Therapeutics, Inc
- The debt of Protagonist Therapeutics, Inc
- All of Protagonist Therapeutics, Inc's financials, charted
Companies of a similar size
Not investment advice. This page shows what Protagonist Therapeutics, Inc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.